Medical Affairs Consultant > Joboolo FR :

Apply locations:


European Union

- Remote, posted on:


9 Days Ago, job requisition id:


REQ-3204

Position Purpose:

The Integrated Medical Affairs and Evidence Generation group delivers ambitious, patient-focused cross-regional and cross-indication medical strategies, driving data generation and dissemination, to maximise patient benefit from argenx products.

The Medical Director will provide expert medical leadership to guide development, launch planning, life cycle management, and support for approved products, working in collaboration with cross-functional colleagues.

Key Accountabilities/Responsibilities:

1. Provide expert medical input to guide clinical development, comprehensive evidence generation, launch planning, and brand plan execution in relevant indications.


2. Develop and execute ambitious short-term and long-term medical strategies, as key elements of the integrated data generation plan and brand plan.


3. Align global medical affairs activities in partnership with other cross-functional colleagues.


4. Develop close partnerships with regional and country medical affairs leads/teams, and the regional indication strategy teams, ensuring all activities maximise cross-regional impact while enabling regional team empowerment and supporting local delivery.


5. Initiate and support high-impact medical activities, such as advisory boards, congress symposia, and medical research projects.


6. Drive the identification and development of productive collaborations, including with healthcare organisations, experts, other important customers and stakeholders, and professional organizations.


7. Support implementation and advancement of Medical Affairs data generation mechanisms, including phase 4 and collaborative studies.


8. Identify and implement impactful data generation projects and strategy development for investigator-sponsored studies and assessment of proposals.


9. Partner with scientific communications to support the development of publication and medical education strategies.


10. Develop and continuously maintain the highest scientific and medical expertise with relevant diseases and products, being acknowledged internally and externally as an expert.


11. Ensure all medical affairs activities maintain the highest standards, complying with applicable pharmaceutical regulations, as well as argenx policies and procedures.

Skills and Competencies:

• Able to quickly understand complex disease areas, treatments, and development and brand strategies.


• Proven track record of building productive collaborations with external medical experts and networks to gain actionable insights.


• Understands how to build internal cross-functional and cross-regional collaborations, ensuring broad input to decision making.


• Embraces innovation and shared goals.


• Excellent communication skills:
  
  
  verbal, written, and when giving presentations.


• Strong influencing skills to engage effectively with internal and external stakeholders.


• Able to thrive as part of a team and when working independently.


• Proven track record of delivering results that meet or exceed targeted objectives.


• Fluency in English, in addition to the local language(s), both oral and written.

Education, Experience and Qualifications:

• Scientific, healthcare or medical degree (BSc, MS, PhD, PharmD, RN, MBBS, MB.ChB or equivalent).


• Substantial medical affairs experience throughout the product lifecycle.


• A strong understanding of the drug development process and launch planning.


• Relevant drug development, therapeutic area expertise, and existing external expert network is an advantage.


• Robust knowledge of regulations and practices related to industry interactions with healthcare professionals.


• Experience partnering with regional/country and global functions and leadership.

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.


Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.


argenx is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier-stage experimental medicines within its therapeutic franchises.


argenx has offices in Belgium, the United States, Japan, and Switzerland.